IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 394 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $244 | -100.0% | 5,956 | -79.8% | 0.00% | -87.5% |
| Q2 2022 | $1,091,000 | +4.7% | 29,479 | +4.8% | 0.01% | +14.3% |
| Q1 2022 | $1,042,000 | +35.9% | 28,122 | +11.5% | 0.01% | +16.7% |
| Q4 2021 | $767,000 | -7.1% | 25,217 | +2.4% | 0.01% | -14.3% |
| Q3 2021 | $826,000 | -9.1% | 24,614 | +8.0% | 0.01% | -12.5% |
| Q2 2021 | $909,000 | +1.6% | 22,786 | +14.5% | 0.01% | -11.1% |
| Q1 2021 | $895,000 | +343.1% | 19,896 | +495.0% | 0.01% | +200.0% |
| Q4 2019 | $202,000 | -1.5% | 3,344 | -2.5% | 0.00% | 0.0% |
| Q3 2019 | $205,000 | -22.9% | 3,430 | -17.0% | 0.00% | -25.0% |
| Q2 2019 | $266,000 | +6.0% | 4,134 | +33.4% | 0.00% | 0.0% |
| Q1 2019 | $251,000 | +4.1% | 3,098 | -33.6% | 0.00% | 0.0% |
| Q3 2018 | $241,000 | – | 4,669 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |